SIR-This study examined the association between country of birth and type of dementia in a representative community sample of people aged 65 years and older in Britain. Both dementia overall, and the vascular subtype, were over represented among people born in Africa or the Caribbean compared with people born in the UK, despite the greater age of the latter group. People from Africa or the Caribbean with either a history of hypertension or current hypertension were signiWcantly more likely to have dementia if they were not prescribed the appropriate antihypertensive for this group. People in this group should be screened and treated for hypertension to reduce the risk of dementia.
Background
There are few community studies which have compared prevalence rates of dementia in different ethnic groups. Our group identiWed having Africa or the Caribbean as the country of birth (COB) compared to the UK to be a signiWcant independent predictor of dementia [1] and found that this was not accounted for by language, education or age. Similarly, a pilot UK study suggested a higher rate of dementia in African/Caribbeans compared with the rate, which had been age and gender matched, in white residents [2] . Hendrie et al. [3] compared the prevalence of dementia between community-dwelling people living in Nigeria and AfricanAmericans living in Indianapolis and found a signiWcantly decreased rate in Nigeria (2.3 versus 4.8%). The Yoruba group also showed a signiWcantly lower incidence of dementia (1.4 versus 3.2%) [4] . The investigators felt that there was potential to identify modiWable factors by further comparison of those two groups.
Few studies have examined the relationship between ethnicity and type of dementia despite the well-documented excess of hypertension in the African/Caribbean population in the West [5] and increased mortality in this group from cerebrovascular disease [6] . The purpose of the present study was to determine the association between African/Caribbean COB compared to UK COB and type of dementia, in a representative community sample of older people, and to explore whether people of African/Caribbean birth with hypertension were taking the treatments for this group which have been demonstrated to be the most effective (a diuretic or a calcium channel blocker [7] ). Blood pressure (BP) measurements were obtained on 53 people assessed at stage 2. Hypertension is here deWned as a pressure > 140/90 mm Hg [8 ] .
Method and Results
Participants were recruited from a door-to-door survey in a relatively deprived inner London borough, Islington. Demographic information was collected, including COB. A validated screening instrument for dementia, the Short-CARE, was used. We performed a follow-up assessment on people who screened positive for dementia, including a history from participant, informant and medical notes, mental state examination including cognitive assessment (using the Mini-Mental State Examination and tests of frontal lobe function), physical examination and laboratory tests [9] . Two raters made diagnoses in accordance with the Diagnostic and Statistical Manual (DSM) IV and International ClassiWcation of Diseases (ICD) 10. In addition, diagnoses were made using the best-validated criteria for probable and possible Alzheimer's disease and vascular dementia, respectively, the McKhann [10] and Roman [11] criteria.
One thousand and eighty-Wve people were interviewed. In the UK-born group there were 667 (61.5%) and the Africa/ Caribbean-born group 98 (9.1%). Rates of dementia were UK 67 (10.0%) and African/Caribbean 17 (17.3%). Dementia type was diagnosed in 72 people (67.3% of screen-positive). Of these, 47 (65.3%) were born in the UK, 10 (13.9%) in Africa/Caribbean. There was no signiWcant difference in terms of COB or gender between those followed up and those not. Table 1 shows the dementia types according to diagnostic criteria and COB. The proportion of African/Caribbean people with dementia who have the vascular type was consistently high according to all criteria.
Ninety-eight people were born in Africa/Caribbean, of whom 58 (59.2%) were female. The age range was 65-96 years; 
Comments
This is the Wrst study to consider the prevalence of subtypes of dementia in a group of African/Caribbeans and compare it to a control group. Vascular dementia was the commonest subtype and was over-represented in African/Caribbeans. This was despite the signiWcantly younger median age of this group. People in this group were not always aware that they had hypertension and were signiWcantly more likely to have dementia if they were not prescribed the correct antihypertensives. The different prevalence rate of hypertension is likely to be related to lifestyle factors such as diet, rather than 'racial' characteristics.
There are difWculties in cross-cultural diagnoses of dementia, but a normative test battery for cognitive function in African/Caribbean elders in the UK shows that scores on memory tests were comparable with normative data for African-American populations [12] . In addition, a 1-year follow-up study of a multicultural community sample of people who had been diagnosed with dementia found that stability of diagnosis did not vary according to ethnic background [13] . The diagnoses therefore can be given with some conWdence.
We have found a potentially modiWable environmental factor for the increase in dementia. Despite the small numbers in this study and the fact that blood pressure was measured only once in each case, the signiWcant Wndings imply that it is imperative that people born in African/Caribbean countries and living in the UK should be screened for hypertension and treated appropriately to reduce the risk of dementia.
Key points
• Dementia and speciWcally vascular dementia is overrepresented among elders born in Africa or the Caribbean and living in Britain.
• African/Caribbean-born people commonly have hypertension which is either undiagnosed or treated with inappropriate medication.
• People in this group are signiWcantly more likely to have dementia if their hypertension is undiagnosed or inadequately treated.
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Dr Stevens assisted with data collection and analysis, and wrote the bulk of the manuscript. Mr Leavey contributed to data analysis and the writing of the paper. Dr Livingston supervised the project, and contributed to data analysis and writing of the paper. The impact of self-reported cumulative comorbidity on stroke recovery SIR-Comorbid disease is common in stroke survivors but studies of stroke recovery have rarely identiWed comorbid conditions as predictors [1] [2] [3] [4] [5] [6] [7] Comorbid health problems consistently affect survival and utilisation regardless of condition, and have modest associations with concurrent functional status, but comorbid illness and function have independent effects on survival and utilisation [8] [9] [10] [11] [12] . The severity of comorbid illnesses may be measured in part by impact on activity and function [8, [13] [14] [15] [16] [17] [18] , producing conceptual and analytic overlap in measures of comorbidity and function. In inpatient rehabilitation settings, where baseline functional status predicts recovery, comorbid illness has a modest and inconsistent effect on outcome [1, 9, 19, 20] . The effect of self-reported comorbid burden on stroke recovery after discharge from institutional settings is not known. This study examines the effect of comorbid burden of disease, independent of stroke severity, age and function, on stroke recovery over 6 months.
Methods

Overview
This is a prospective cohort study of stroke survivors in the Kansas City Stroke Study (KCSS). The protocol was approved by the Institutional Review Board. All subjects were seen within 2 weeks after stroke, and reassessed at 1, 3 and 6 months at their residence. A full description of study methods has been published [2] and is summarised here.
Subjects
The KCSS recruited stroke survivors from 12 participating hospitals within the Wrst 14 days since stroke (median 8 days). An eligible stroke was deWned by the WHO criteria and was conWrmed by clinical assessment and/or by a CT/MRI scan. The comorbidity index was introduced into this study after data collection had begun and was subsequently collected in all consecutive participants.
Procedures and measures
Assessments included baseline demographics, prior function, stroke characteristics, and general functional status measures [2] . The Comorbidity Disease Index is a patient self-report measure which includes conditions that are relevant to rehabilitation. The 19 items were classiWed into eight domains, as shown in Table 1 . Since stroke was the primary diagnosis, it was excluded as a comorbidity. The comorbid burden score is the sum of involved domains. When Wrst developed, the comorbidity scale included degree of limitation attributed to each condition to reXect severity. Since limitation is related to function, and because limitation did not increase explained variance in our prior analyses with both baseline function and comorbid burden, we did not include severity in the score [21] . Comorbidity self-reports were collected at the baseline interview of patients and/or proxies (8.7% by proxy).
Risk factors for stroke were abstracted from the medical record using a structured tool. Conditions that were col- 
